Atlas Trials

Apremilast 30mg Bid With Narrowband UVB in the Treatment of Plaque Psoriasis

Clinical trial NCT02412644 · COMPLETED

Trial details

NCT number
NCT02412644
Sponsor
Psoriasis Treatment Center of Central New Jersey
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Plaque Psoriasis
Start date
2015-05-28
Primary completion
2016-07-01
Enrollment
29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.